Evidence map›Paper›PMID 33687546›Full record

ArticleHeart and vessels2021

Correction to: Long-term administration of tolvaptan ameliorates annual decline in estimated glomerular filtration rate in outpatients with chronic heart failure.

Kazuhiro Nakao, Takeshi Horio, Ryutaro Yoshimura, Ryosuke Fujiwara, Yujiro Matsuoka, Go Yokouchi, Haruo Nakamura, Yuya Sakamoto, Kohei Fujimoto, Yasuhiro Izumiya and 2 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kazuhiro NakaoDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Takeshi HorioDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan. t-horio@ishikiriseiki.or.jp.
Ryutaro YoshimuraDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Ryosuke FujiwaraDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Yujiro MatsuokaDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Go YokouchiDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Haruo NakamuraDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Yuya SakamotoDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Kohei FujimotoDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.
Yasuhiro IzumiyaDepartment of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Minoru YoshiyamaDepartment of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Noriaki KasayukiDepartment of Cardiovascular Medicine, Ishikiriseiki Hospital, 18-28, Yayoi-cho, Higashi-Osaka, 579-8026, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33687546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.